 CAMBRIDGE, Mass., June 07, 2021 GLOBE NEWSWIRE -- Solid Biosciences Inc. Nasdaq: SLDB, a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy Duchenne, today announced that Dr. Iman Barilero has joined the Company as Chief Regulatory Officer, effective June 1, 2021. 